News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Affymetrix (Bedford, Massachusetts) (AFFX) Clinical Services Laboratory and DOCRO Join Forces to Accelerate the Commercialization of In Vitro Diagnostic Products


7/16/2007 11:16:54 AM

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) announced today that the Affymetrix Clinical Services Laboratory (ACSL) has signed a co-marketing agreement with DOCRO Inc., a leading contract research organization (CRO) that specializes in the commercialization of in vitro diagnostic (IVD) biomarker technologies. The two companies will work together to help customers gain clearance or approval of IVD products from the U.S. Food and Drug Administration (FDA) and bring those products to market faster than before.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES